Joint Corp (NASDAQ:JYNT) Director Ronald V. Davella sold 3,000 shares of the company’s stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $7.62, for a total value of $22,860.00. Following the sale, the director now owns 15,797 shares in the company, valued at approximately $120,373.14. The sale was disclosed in a filing with the SEC, which is available through this link.

Shares of NASDAQ:JYNT opened at $7.65 on Friday. The company has a market capitalization of $101.50 million, a price-to-earnings ratio of -30.60 and a beta of 1.02. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.36 and a current ratio of 1.36. Joint Corp has a 52-week low of $4.67 and a 52-week high of $9.64.

Joint (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, November 8th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). The firm had revenue of $8.06 million during the quarter, compared to the consensus estimate of $7.98 million. Joint had a negative return on equity of 21.00% and a negative net margin of 2.68%. Equities research analysts anticipate that Joint Corp will post 0.06 earnings per share for the current year.

A number of large investors have recently made changes to their positions in the business. Advisory Services Network LLC boosted its holdings in Joint by 42.6% in the third quarter. Advisory Services Network LLC now owns 27,780 shares of the company’s stock worth $238,000 after acquiring an additional 8,299 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in Joint by 20,991.5% in the second quarter. Tower Research Capital LLC TRC now owns 12,444 shares of the company’s stock worth $102,000 after acquiring an additional 12,385 shares in the last quarter. Spark Investment Management LLC bought a new position in Joint in the second quarter worth approximately $134,000. Perkins Capital Management Inc. lifted its holdings in shares of Joint by 33.0% in the third quarter. Perkins Capital Management Inc. now owns 68,500 shares of the company’s stock valued at $586,000 after purchasing an additional 17,000 shares in the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of Joint by 7.0% in the third quarter. Vanguard Group Inc. now owns 276,974 shares of the company’s stock valued at $2,368,000 after purchasing an additional 18,099 shares in the last quarter. Institutional investors and hedge funds own 51.43% of the company’s stock.

JYNT has been the topic of several recent research reports. Roth Capital reiterated a “buy” rating on shares of Joint in a report on Friday, August 10th. Zacks Investment Research upgraded Joint from a “hold” rating to a “buy” rating and set a $9.75 price target on the stock in a report on Wednesday, August 15th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $10.58.

ILLEGAL ACTIVITY NOTICE: “Joint Corp (JYNT) Director Sells $22,860.00 in Stock” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://www.watchlistnews.com/joint-corp-jynt-director-sells-22860-00-in-stock/2670732.html.

Joint Company Profile

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of August 9, 2018, the company operated approximately 400 clinics. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.

Featured Story: Capital Gains

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.